EBioMedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2022-03-29 122863d1m37(暂无昵称)

请问各位前辈这个杂志一般几天送审啊

454 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2020-04-06 洪诗福

你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表:
好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档

珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档

29 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2022-03-21 土豆马铃薯

审稿速度:6.0
经验分享：今天刚投，希望有好消息吧......

484 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2021-03-22 146f239fm10(暂无昵称)

现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~

0 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2021-11-20 华家池陈冠希

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：脑血管病
经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑

530 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2019-11-05 Leoharlan

审稿速度:3.0 | 投稿命中率:25.0
经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。
编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！
之后有问题的朋友可以交流

381 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2025-06-10 ms6000002977722155 来自上海

审稿数度还挺快，我一审35天
录用后15天在线发表
3名审稿人，给了一些修改意见
整体来说对中国作者挺友好的，近年来国人发文量也特别大。
新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受
还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。

468 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2023-11-07 ms4000002052355520 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：微生态
经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去.

532 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2016-03-14 刘洋1981

你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表::
我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右

fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右

687 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206789, encodeId=a9fa1206e8984, content=请问各位前辈这个杂志一般几天送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2cbb2338538, createdName=122863d1m37(暂无昵称), createdTime=Tue Mar 29 07:52:55 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588301, encodeId=671658830116, content=你好，我想请问一下，投稿里面有个剽窃检查plagiarism check 怎么填啊，好像是必填的，是要填自己的查重结果么？珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, beContent=珑铭臻 2020-03-13 00:00:00 发表: 好像没有您说的这么复杂，我只是提交了一份电子签名的PDF文档, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffdc5315297, createdName=洪诗福, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204541, encodeId=04b51204541bc, content=审稿速度:6.0 经验分享：今天刚投，希望有好消息吧......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/5ec5e7fd3f12435c953afd2cf3243a85/0d33baf71ce9406587c3e3df6bd5cddf.png, createdBy=26c52392155, createdName=土豆马铃薯, createdTime=Mon Mar 21 09:34:57 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950158, encodeId=446595015886, content=现在投稿还需要提供western的原始数据吗？看补充材料里都是western的原图~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Mon Mar 22 19:31:30 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072161, encodeId=549710e21610d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑血管病 经验分享：2021.09.04投稿，10.21required review completed，中间时间变过2次，目前还没结果，忐忑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=530, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2Ihru37tYR0I4UYvbFldUVeNOAIsblQf2A5JEzK2Bg6mA1vwcloXr5QJXx3UyEVQOhD9k6picltA/132, createdBy=b63f1951030, createdName=华家池陈冠希, createdTime=Sat Nov 20 11:22:52 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579392, encodeId=e7cb5e9392b9, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：6.22投的搞，7天后就审完了，给2个月的时间大修，9.29号返修回去，又审了一个月，本来想催一下，因为这个杂志平时审稿都挺快的。那不知到了整整一个月的时候说基本快接受了，还改一下p值和统计学，当天返回去第二天就接受了。历时4个月，主要是自己返修了2月，总体是很快的。 编辑推荐参选封面文章，现在正在找公司画图，希望能做封面！！！ 之后有问题的朋友可以交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqrktn59XpSJFcx3ZZRaiayeeUqgtmibRhUqqH8MXHtW3a1mt6AOeBqYrGFN0Vib60wvhAD5fcyiaxVLg/132, createdBy=b6b21645984, createdName=Leoharlan, createdTime=Tue Nov 05 16:28:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2268796, encodeId=159e2268e9674, content=审稿数度还挺快，我一审35天 录用后15天在线发表 3名审稿人，给了一些修改意见 整体来说对中国作者挺友好的，近年来国人发文量也特别大。 新型治疗靶点/标志物发现/疾病机制与干预路径验证/多组学整合诊断工具开发等内容都接受 还有需要注意的是：投稿避开12月（圣诞假期），首选3-4月或9-10月投稿，审稿人活跃期，效率会比较高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Tue Jun 10 22:41:00 CST 2025, time=2025-06-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212089, encodeId=e86912120892b, content=Submitted to Journal这个状态一般会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Mon Apr 18 08:31:05 CST 2022, time=2022-04-18, status=1, ipAttribution=)]

2022-04-18 1ddf3775m09(暂无匿称)

Submitted to Journal这个状态一般会持续多久？

225 3 举报

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务